pantoprazole has been researched along with Allergic Reaction in 1 studies
Pantoprazole: 2-pyridinylmethylsulfinylbenzimidazole proton pump inhibitor that is used in the treatment of GASTROESOPHAGEAL REFLUX and PEPTIC ULCER.
pantoprazole : A member of the class of benzimidazoles that is 1H-benzimidazole substituted by a difluoromethoxy group at position 5 and a [(3,4-dimethoxypyridin-2-yl)methyl]sulfinyl group at position 2.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Since Omeprazole and pantoprazole decrease the secretion of TCTP which is associated with the development of allergic reaction, they may have the potential to serve as anti-allergic (asthmatic) drugs." | 3.75 | Proton pump inhibitors exert anti-allergic effects by reducing TCTP secretion. ( Choi, S; Hwang, ES; Kim, M; Lee, K; Min, HJ, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, S | 1 |
| Min, HJ | 1 |
| Kim, M | 1 |
| Hwang, ES | 1 |
| Lee, K | 1 |
1 other study available for pantoprazole and Allergic Reaction
| Article | Year |
|---|---|
Proton pump inhibitors exert anti-allergic effects by reducing TCTP secretion.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Allergic Agents; Anti-Ulcer Agents; Biomarker | 2009 |